A Transcriptional Signature for Active TB: Have We Found the Needle in the Haystack?
article has not abstract
Vyšlo v časopise:
A Transcriptional Signature for Active TB: Have We Found the Needle in the Haystack?. PLoS Med 10(10): e32767. doi:10.1371/journal.pmed.1001539
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001539
Souhrn
article has not abstract
Zdroje
1. BerryMP, GrahamCM, McNabFW, XuZ, BlochSA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973–977.
2. JacobsenM, RepsilberD, GutschmidtA, NeherA, FeldmannK, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 85: 613–621.
3. KothLL, SolbergOD, PengJC, BhaktaNR, NguyenCP, et al. (2011) Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med 184: 1153–1163.
4. MaertzdorfJ, WeinerJ3rd, MollenkopfHJ, BauerT, PrasseA, et al. (2012) Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 109: 7853–7858.
5. WhitingP, RutjesAW, ReitsmaJB, GlasAS, BossuytPM, et al. (2004) Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 140: 189–202.
6. SimonRM, DobbinK (2003) Experimental design of DNA microarray experiments. Biotechniques Suppl: 16–21.
7. JaniIV, PeterTF (2013) How point-of-care testing could drive innovation in global health. N Engl J Med 368: 2319–2324.
8. LordSJ, IrwigL, BossuytPM (2009) Using the principles of randomized controlled trial design to guide test evaluation. Med Decis Making 29: E1–E12.
9. World Health Organization (2011) Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in esource-constrained settings. Geneva: WHO Press.
10. World Health Organization (2012) Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. Geneva: WHO Press.
11. IrwinRJ, IrwinTC (2011) A principled approach to setting optimal diagnostic thresholds: where ROC and indifference curves meet. Eur J Intern Med 22: 230–234.
12. BossuytPM, ReitsmaJB, BrunsDE, GatsonisCA, GlasziouPP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138: 40–44.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 10
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
- Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
- Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study
- Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study